Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: Design and baseline characteristics of the Alpha Omega Trial

American Heart Journal

Volumn 159, Issue 4, 2010, Pages

  Geleijnse, Johanna M ^a   Giltay, Erik J ^b   Schouten, Evert G ^a   de Goede, Janette ^a   Oude Griep, Linda M ^a   Teitsma Jansen, Anna M ^a   Katan, Martijn B ^c   Kromhout, Daan ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LINOLENIC ACID; PLACEBO; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FATTY ACID BLOOD LEVEL; FEMALE; GROUPS BY AGE; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STROKE;

EID: 77950146470     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.033     Document Type: Article

References (29)

1. Bang H.O., and Dyerberg J. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28 (1975) 958-966
2. Kromhout D., Bosschieter E.B., and de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Eng J Med 312 (1985) 1205-1209
3. He K., Song Y., Daviglus M.L., et al. Accumulated evidence on fish consumption and coronary heart disease mortality. A meta-analysis of cohort studies. Circulation 109 (2004) 2705-2711
4. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296 (2006) 1885-1899
5. Léon H., Shibata M.C., Sivakumaran S., et al. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 337 (2008) a2931
6. Iso H., Kobayashi M., Ishihara J., et al., JPHC Study Group. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113 (2006) 195-202
7. Yokoyama M., Origasa H., Matsuzaki M., et al. lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007) 1090-1098
8. Keli S.O., Feskens E.J., and Kromhout D. Fish consumption and risk of stroke. The Zutphen Study. Stroke 25 (1994) 328-332
9. He K., Song Y., Daviglus M.L., et al. Fish consumption and incidence of stroke. A meta-analysis of cohort studies. Stroke 35 (2004) 1538-1542
10. Brouwer I.A., Katan M.B., and Zock P.L. Dietary α-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk. A meta-analysis. J Nutr 134 (2004) 919-922
11. Wang C., Harris W.S., Chung M., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
12. Harris W.S. Cardiovascular risk and alpha-linolenic acid: can Costa Rica clarify?. Circulation 118 (2008) 323-324
13. Campos H., Baylin A., and Willett W.C. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 118 (2008) 339-345
14. Simon J.A., Fong J., Bernert Jr. J.T., et al. Serum fatty acids and the risk of stroke. Stroke 26 (1995) 778-782
15. Harris W.S., Mozaffarian D., Lefevre M., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139 (2009) 804S-819S
16. Simopoulos A.P., Leaf A., and Salem Jr. N. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 18 (1999) 487-489
17. Kris-Etherton P.M., Innis S., American Dietetic Association, et al. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 107 (2007) 1599-1611
18. Feunekes G.I., Van Staveren W.A., De Vries J.H., et al. Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr 58 (1993) 489-496
19. Schuit A.J., Schouten E.G., Westerterp K.R., et al. Validity of the physical activity scale for the elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol 50 (1997) 541-546
20. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification System (ATC) (2009), World Health Organization, Oslo
21. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
22. Giltay E.J., Geleijnse J.M., Schouten E.G., et al. High stability of markers of cardiovascular risk in blood samples. Clin Chem 49 (2003) 652-655
23. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of LDL cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
24. Glatz J.F., Soffers A.E., and Katan M.B. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr 49 (1989) 269-276
25. WHO. International Statistical Classification of Diseases and Related Health Problems, 10th revision vol. 1 (1992), World Health Organization, Geneva
26. Zock P.L., Mensink R.P., Harryvan J., et al. Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol 145 (1997) 1114-1122
27. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2 (1989) 757-761
28. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
29. Matsuzaki M., Yokoyama M., Saito Y., et al., Jelis Investigators. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J 73 (2009) 1283-1290